Intrinsiqq
Eckert & Ziegler SE logo

Eckert & Ziegler SE Quality Score

EUZ.XETR

⊜ Compare
Quality74

Growth remains strong (avg 85/100), but valuation is pulling the composite down (avg 65/100).

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
90/100
17.7x

Under 20x, reasonable relative to earnings

Cash Flow Multiple
40/100
37.1x

Above 30x, cash flow yield is thin

Revenue Growth
70/100
8.9%

5–10% CAGR, steady but not exceptional

Cash Flow Growth
100/100
34.7%

Above 10% CAGR, strong compounder

Business Quality & Capital Allocation

Share Dilution
0/100
198.2%

Heavy dilution above 5%

Margin Trend
100/100
+3.1pp

Expanded 3+pp, strong improvement

Capital Structure
100/100
-€84M

Net cash position, no leverage concern

2022
€83.0M
€50.0M
2023
€68.0M
€56.0M
2024
€118M
€55.0M
2025
€129M
€45.0M
CashDebt
Return on Capital
80/100
17.6%

15–20%, well above cost of capital

Customize WeightsPremiumUpgrade

Eckert & Ziegler (EUZ.XETR) quality: score, margins and returns

Eckert & Ziegler (EUZ.XETR) scores 74/100 on Intrinsiqq's quality score (a solid business), a weighted blend of 8 metrics each scored 0 to 100, on 23.8% operating margins and 17.6% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is Eckert & Ziegler (EUZ.XETR) a high-quality business?+

Eckert & Ziegler scores 74 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a solid business on these measures. Recent figures include a 23.8% operating margin and a 17.6% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Eckert & Ziegler's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from EUZ.XETR's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Eckert & Ziegler scores well and where it falls behind.

What is Eckert & Ziegler's return on invested capital (ROIC)?+

Eckert & Ziegler earns about 17.6% on its invested capital, which is strong. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to EUZ.XETR's margins and growth on this scorecard to judge durability.

How profitable is Eckert & Ziegler?+

Eckert & Ziegler runs an operating margin of about 23.8% and a net margin of about 16.0%. Revenue has grown at roughly 14.7% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

How the market compares: US profitability statistics

Peers

Medical Devices · Pick stocks to compare with EUZ.XETR

CompareIntrinsic value
M12.XETRM1 Kliniken AG
€18.86-0.74%91
MAK.XETRMaternus-Kliniken Aktiengesellschaft
€0.86-2.84%61
V3V.XETRFamiCord AG
€2.68-3.94%39
AJ91.XETRDocCheck AG
€10.50+0.00%57
7V0.XETRDarwin AG
€6.30-3.08%24
LIK.XETRLimes Schlosskliniken AG
€530.00+1.92%67
FYB.XETRFormycon AG
€18.68-1.68%10
DMP.XETRDermapharm Holding SE
€38.90+1.17%49

Held by ETFs

EUZ.XETR is in 11 US ETFs. The largest of them, with EUZ.XETR's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing EUZ.XETR

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.